Finetek【131760】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

Finetek (131760)

0.00

0.00

(0.00%)

終了 8月12日 3:30PM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

-

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

前日終値

-

始値

-

時刻

最終取引時間

平均取引量 (3 か月)

-

財務取引量

-

VWAP

-

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update

$478 million in second quarter global net product sales First CIDP patients treated with VYVGART® Hytrulo following June 21st FDA approval On track to begin four additional registrational...

argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024

July 18, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China

First and only NMPA-approved subcutaneous injectable FcRn blocker for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod SC compared to IV demonstrated in...

Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China

First and only NMPA-approved subcutaneous (SC) injectable providing additional flexibility and optionality for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod...

argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting

ARDA study data show potential for empasiprubart to drive functional improvement and reduced risk of relapse for multifocal motor neuropathy (MMN) patients ADHERE+ data show durability of...

argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy

VYVGART® Hytrulo is first and only neonatal Fc receptor (FcRn) blocker approved to treat chronic inflammatory demyelinating polyneuropathy (CIDP) First novel, precision mechanism of action in...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高

elks

Guzzi62

Guzzi62 8分前

They de listed voluntarily which makes it easier to get in again.

louieforpar

louieforpar 8分前

Did MOJO ask for Derangement syndrome?

Trumps Derangement explained:

A deranged CONVICTED FELON,cheater,Liar sometimes requires the shoe to fit.

You sexually assaulted a woman in the dressing room of a clothing’s store. Deranged

dirkv

MULN: 0.5975 🤔
52 Week Range 0.59 - 108.0000
Book Value Per Share (mrq) 7.68
Short % of shares 24.43%

Time for a strong recovery
Today: 24,859,163 shares x 0.5975 = 14.8 M
07/05/2024 16,031,470 shares x 2.42 = 38.8 M
As of May 9,

IceCold8

IceCold8 11分前

Logan please start taking your shareholders into consideration!!!

dirkv

MULN: 0.5975 🤔
52 Week Range 0.59 - 108.0000
Book Value Per Share (mrq) 7.68
Short % of shares 24.43%

Time for a strong recovery
Today: 24,859,163 shares x 0.5975 = 14.8 M
07/05/2024 16,031,470 shares x 2.42 = 38.8 M
As of May 9,

kabunushi

kabunushi 12分前

"The Professor lacks standing." Says the guy who lacks standing to clean the Professor's shoes.

reena969

reena969 20分前

That's intriguing; I also endorse the indicator.

Just the facts maam

Just the facts maam 20分前

I find it interesting that Samy started selling shares a couple of days after the Libigel CVR's expired.

https://finance.yahoo.com/screener/insider/SHANMUGAM%20MUTHUSAMY?count=100&offset=0 Samy's trades

Wolf-man jack

Wolf-man jack 24分前

“ Charlotte's Web Holdings, Inc. (TSE:CWEB) just released its latest quarterly report and things are not looking great. It definitely looks like a negative result overall with revenues falling 14% short of analyst estimates at US$12m. Statutory losses were US$0.07 per share, 40% bigger than what the

diggitydoodle

diggitydoodle 28分前

A new week. Instead of posters pretending things here are great, let's see if the great CEO can do something that makes things great.
GLTA!
RNVA!!$$$$$$?????????????????????

work-n-hard

work-n-hard 29分前

UMAC: 10K/A - As of August 8, 2024, there were 6,184,983 shares of the registrant’s common stock outstanding.

https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318510828&type=HTML&symbol=UMAC&cdn=ebdd7a58f5d3f328a158052d58f48061&companyName=Unusual+Machines+Inc.&for

work-n-hard

work-n-hard 30分前

10K/A - As of August 8, 2024, there were 6,184,983 shares of the registrant’s common stock outstanding.

https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318510828&type=HTML&symbol=UMAC&cdn=ebdd7a58f5d3f328a158052d58f48061&companyName=Unusual+Machines+Inc.&formType=

Bull_Dolphin

Bull_Dolphin 31分前

Here's a cleaner link (without the loud host) showing the black curtain dishonestty:

https://x.com/CollinRugg/status/1822310913221021832

Sauerkraut

Sauerkraut 32分前

Back in for a swing

Tom turtles

Tom turtles 35分前

Senior Executives taking a 40% cut in salary during restructuring of product and Kothari's arrival from Meta. I like what their trying to pull off.

Just the facts maam

Just the facts maam 42分前

That is possibility.

JusticeWillWin

JusticeWillWin 46分前

👉👉👉LATEST $COOP price targets==>UBS:$118, Wedbush:$115, Piper Sandler:$103, Barclays:$101, Compass Point:$97, KBW:$96, DEUTSCHE BANK:$90

See: https://www.marketscreener.com/quote/stock/MR-COOPER-GROUP-INC-46600303/consensus/

somberfox

somberfox 52分前

you're aware that's attached to their bankrupt/nonexistent company right?

TommyJ7651

TommyJ7651 53分前

Thank you for this post! Always nice seeing shareholders being proactive and sharing information.

This is what I have been expecting i.e. bigger individual investors coming into the story now that we are approaching the final EA submission and the share is still dirt cheap. I also no

XMaster2023

XMaster2023 58分前

Roswell was facing the same production issues that NWBO resolved. There is a lot of synergy between the companies.

LuckyLovie

LuckyLovie 1時間前

No that areas a dump..fake estates going to crash with stock market
That's why it's too cheap...stick with wnft or sell half buy the shinny new toy idvv

Nemesis18

Nemesis18 1時間前

It is simply an act of loading provisions off a sinking ship into a lifeboat.

LuckyLovie

LuckyLovie 1時間前

Yup gotcha,I have a few ...

BIOCHEMUP

BIOCHEMUP 1時間前

Lets have a great week here with the Saudi Definitive order agreement.

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約